Search filters

List of works by Véronique Gelsi-Boyer

Array comparative genomic hybridization and sequencing of 23 genes in 80 patients with myelofibrosis at chronic or acute phase

scientific article

BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders.

scientific article

Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias

scientific article

Combined translocation with ZNF198-FGFR1 gene fusion and deletion of potential tumor suppressors in a myeloproliferative disorder

scientific article published on March 2007

Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancers

scientific article

Gene mutations differently impact the prognosis of the myelodysplastic and myeloproliferative classes of chronic myelomonocytic leukemia

article

Genome profiling of chronic myelomonocytic leukemia: frequent alterations of RAS and RUNX1 genes

scientific article

Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias

scientific article published on 15 April 2011

Molecular similarity between myelodysplastic form of chronic myelomonocytic leukemia and refractory anemia with ring sideroblasts

scientific article published on 12 October 2012

Mutations in ASXL1 are associated with poor prognosis across the spectrum of malignant myeloid diseases ⬇️

scientific article published on March 21, 2012

Myeloid malignancies: mutations, models and management ⬇️

scientific article published on July 23, 2012

Prognostic score including gene mutations in chronic myelomonocytic leukemia.

scientific article

SETBP1 mutations in 658 patients with myelodysplastic syndromes, chronic myelomonocytic leukemia and secondary acute myeloid leukemias.

scientific article published on 5 February 2013

TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia

scientific article published on October 2009

TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs).

scientific article

Paulina is supported by:

About Paulina

Help